181 related articles for article (PubMed ID: 35860243)
41. The Hippo Pathway Effector Transcriptional Co-activator With PDZ-Binding Motif Correlates With Clinical Prognosis and Immune Infiltration in Colorectal Cancer.
Wang Y; Nie H; Li H; Liao Z; Yang X; He X; Ma J; Zhou J; Ou C
Front Med (Lausanne); 2022; 9():888093. PubMed ID: 35865173
[TBL] [Abstract][Full Text] [Related]
42. BMPR2 expression level is correlated with low immune infiltration and predicts metastasis and poor survival in osteosarcoma.
Cao H; Quan S; Zhang L; Chen Y; Jiao G
Oncol Lett; 2021 May; 21(5):391. PubMed ID: 33777214
[TBL] [Abstract][Full Text] [Related]
43. ETV1, 4 and 5: an oncogenic subfamily of ETS transcription factors.
Oh S; Shin S; Janknecht R
Biochim Biophys Acta; 2012 Aug; 1826(1):1-12. PubMed ID: 22425584
[TBL] [Abstract][Full Text] [Related]
44. High Expression of the Component 3a Receptor 1 (C3AR1) Gene in Stomach Adenocarcinomas Infers a Poor Prognosis and High Immune-Infiltration Levels.
Yang H; Li L; Liu X; Zhao Y
Med Sci Monit; 2021 Feb; 27():e927977. PubMed ID: 33539329
[TBL] [Abstract][Full Text] [Related]
45. Prognostic value of ubiquitin E2 UBE2W and its correlation with tumor-infiltrating immune cells in breast cancer.
Yuan Y; Xiao WW; Xie WH; Li RZ; Gao YH
BMC Cancer; 2021 Apr; 21(1):479. PubMed ID: 33931024
[TBL] [Abstract][Full Text] [Related]
46. PEA3/ETV4-related transcription factors coupled with active ERK signalling are associated with poor prognosis in gastric adenocarcinoma.
Keld R; Guo B; Downey P; Cummins R; Gulmann C; Ang YS; Sharrocks AD
Br J Cancer; 2011 Jun; 105(1):124-30. PubMed ID: 21673681
[TBL] [Abstract][Full Text] [Related]
47. The possible role of SRMS in colorectal cancer by bioinformatics analysis.
Zhang J; Liu W; Feng S; Zhong B
World J Surg Oncol; 2021 Nov; 19(1):326. PubMed ID: 34781983
[TBL] [Abstract][Full Text] [Related]
48. Profiles of immune infiltration in colorectal cancer and their clinical significant: A gene expression-based study.
Xiong Y; Wang K; Zhou H; Peng L; You W; Fu Z
Cancer Med; 2018 Sep; 7(9):4496-4508. PubMed ID: 30117315
[TBL] [Abstract][Full Text] [Related]
49. The Effects of Differentially-Expressed Homeobox Family Genes on the Prognosis and HOXC6 on Immune Microenvironment Orchestration in Colorectal Cancer.
Qi L; Ye C; Zhang D; Bai R; Zheng S; Hu W; Yuan Y
Front Immunol; 2021; 12():781221. PubMed ID: 34950145
[TBL] [Abstract][Full Text] [Related]
50. Expression, Prognosis, and Immune Infiltrates Analyses of E2Fs in Human Brain and CNS Cancer.
Liao P; Han S; Qu H
Biomed Res Int; 2020; 2020():6281635. PubMed ID: 33381564
[TBL] [Abstract][Full Text] [Related]
51. M2-Type Macrophages and Cancer-Associated Fibroblasts Combine to Promote Colorectal Cancer Liver Metastases.
Feng Y; Qiao S; Chen J; Wen X; Chen Y; Song X; Xu J; Qiao X; Yang J; Zhang S; Feng Y; Gao Y
Onco Targets Ther; 2024; 17():243-260. PubMed ID: 38558848
[TBL] [Abstract][Full Text] [Related]
52. Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis.
Chen YF; Yu ZL; Lv MY; Cai ZR; Zou YF; Lan P; Wu XJ; Gao F
Mol Med; 2021 Oct; 27(1):139. PubMed ID: 34717544
[TBL] [Abstract][Full Text] [Related]
53. Immune landscape and prognostic immune-related genes in KRAS-mutant colorectal cancer patients.
Liu J; Huang X; Liu H; Wei C; Ru H; Qin H; Lai H; Meng Y; Wu G; Xie W; Mo X; Johnson CH; Zhang Y; Tang W
J Transl Med; 2021 Jan; 19(1):27. PubMed ID: 33413474
[TBL] [Abstract][Full Text] [Related]
54. Cooperation between ETS transcription factor ETV1 and histone demethylase JMJD1A in colorectal cancer.
Oh S; Song H; Freeman WM; Shin S; Janknecht R
Int J Oncol; 2020 Dec; 57(6):1319-1332. PubMed ID: 33174020
[TBL] [Abstract][Full Text] [Related]
55. PPM1D is a potential prognostic biomarker and correlates with immune cell infiltration in hepatocellular carcinoma.
Yu Z; Song Y; Cai M; Jiang B; Zhang Z; Wang L; Jiang Y; Zou L; Liu X; Yu N; Mao X; Peng C; Liu S
Aging (Albany NY); 2021 Sep; 13(17):21294-21308. PubMed ID: 34470916
[TBL] [Abstract][Full Text] [Related]
56. Prognostic Biomarker SPOCD1 and Its Correlation with Immune Infiltrates in Colorectal Cancer.
Gan L; Yang C; Zhao L; Wang S; Gao Z; Ye Y
Biomolecules; 2023 Jan; 13(2):. PubMed ID: 36830578
[TBL] [Abstract][Full Text] [Related]
57. Development of an Immune Infiltration-Related Eight-Gene Prognostic Signature in Colorectal Cancer Microenvironment.
Wu B; Tao L; Yang D; Li W; Xu H; He Q
Biomed Res Int; 2020; 2020():2719739. PubMed ID: 32908876
[TBL] [Abstract][Full Text] [Related]
58. LPAR2 correlated with different prognosis and immune cell infiltration in head and neck squamous cell carcinoma and kidney renal clear cell carcinoma.
Sun K; Chen RX; Li JZ; Luo ZX
Hereditas; 2022 Mar; 159(1):16. PubMed ID: 35241179
[TBL] [Abstract][Full Text] [Related]
59. Profiles of immune cell infiltration and immune-related genes in the tumor microenvironment of colorectal cancer.
Ge P; Wang W; Li L; Zhang G; Gao Z; Tang Z; Dang X; Wu Y
Biomed Pharmacother; 2019 Oct; 118():109228. PubMed ID: 31351430
[TBL] [Abstract][Full Text] [Related]
60. Pan-cancer analyses demonstrate that ANKRD6 is associated with a poor prognosis and correlates with M2 macrophage infiltration in colon cancer.
Bai R; Wu D; Shi Z; Hu W; Li J; Chen Y; Ge W; Yuan Y; Zheng S
Chin J Cancer Res; 2021 Feb; 33(1):93-102. PubMed ID: 33707932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
